MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$22,367K
Impairment of right-of-use
assets and property and...
$7,348K
Stock-based compensation
expense
$6,628K
Non-cash rent expense
$3,054K
Depreciation expense
$325K
Other non-current
assets
-$176K
Net cash provided by
(used in) operating...
$29,614K
Canceled cashflow
$10,284K
Net (decrease)
increase in cash and cash...
-$15,437K
Canceled cashflow
$29,614K
Proceeds from sales and
maturities of investments
$119,094K
Proceeds from disposal of
equipment
$27K
Non-current operating lease
liability
-$3,713K
Accounts payable
-$3,428K
Accrued expenses and
other current...
-$1,414K
(accretion) amortization on
investments
$1,279K
Prepaid expenses and
other current assets
$349K
Gain on sale of
investments
$74K
Gain on sale of
property and equipment
$27K
Net cash provided by
(used in) investing...
-$44,905K
Canceled cashflow
$119,121K
Net cash provided by
(used in) financing...
-$146K
Purchases of investments
$164,026K
Proceeds from exercise of
common stock options...
-$146K
Back
Back
Cash Flow
source: myfinsight.com
Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. (BDTX)